XML 50 R42.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Anti Dilutive Equity Securities Outstanding (Details)
3 Months Ended
Mar. 31, 2023
shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]  
Anti-dilutive equity securities 20,304,007,000
Series A Preferred Stock [Member]  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]  
Anti-dilutive equity securities 287,500,000 [1]
Series B Preferred Stock [Member]  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]  
Anti-dilutive equity securities 5,299,982,000 [2]
Series C Preferred Stock [Member]  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]  
Anti-dilutive equity securities 1,000,000 [3]
Convertible Debt [Member]  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]  
Anti-dilutive equity securities 13,421,983,333 [4]
Warrant [Member]  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]  
Anti-dilutive equity securities 1,293,541,667 [5]
[1] Each share converts into 50 shares of common stock.
[2] Each share converts into 1,000 shares of common stock.
[3] Each share converts into 1 share of common stock.
[4] Certain notes have exercise prices that have a discount to market and cause variability into the potential amount of common stock equivalents outstanding at each reporting period. As a result, the amount computed for common stock equivalents could change given the quoted closing trading price at each reporting period.
[5] Represents those that are vested and exercisable.